Marksans Pharma Limited has informed the Exchange about Newspaper publication regarding opening of special window for re-lodgement of the transfer request for physical shares
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma has informed the stock exchanges about a newspaper advertisement published on March 12, 2026 in Business Standard and Lakshadeep, informing shareholders about SEBI's extended special window for re-lodging transfer requests of physical shares. Under SEBI Circular dated January 30, 2026, this one-year window (February 5, 2026 to February 4, 2027) applies to shares purchased or sold before April 1, 2019 that were previously rejected, returned, or left unprocessed due to document deficiencies. Shareholders must submit original share certificates, executed transfer deeds, KYC documents, and an indemnity undertaking to the company's RTA, Bigshare Services Private Limited. Successfully transferred shares will be credited only in demat form and will be under a one-year lock-in period from the date of registration.
This is a routine regulatory disclosure with no material impact on the company's business or stock price. It only affects shareholders who hold untransferred physical shares purchased before April 1, 2019, giving them an additional opportunity to regularise those holdings by converting them into demat form.